A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia

Br J Haematol. 2020 Oct;191(2):171-193. doi: 10.1111/bjh.16971. Epub 2020 Jul 30.
No abstract available

Keywords: BCR-ABL; CML; imatinib; tyrosine kinases.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Allografts
  • Aniline Compounds / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Marrow Transplantation*
  • Child
  • Child, Preschool
  • Dasatinib / therapeutic use
  • Drug Resistance, Neoplasm*
  • Female
  • Hematology
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Imidazoles / therapeutic use
  • Interferon-alpha / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / therapy
  • Male
  • Nitriles / therapeutic use
  • Pyridazines / therapeutic use
  • Pyrimidines / therapeutic use
  • Quinolines / therapeutic use
  • Societies, Medical
  • United Kingdom

Substances

  • Aniline Compounds
  • Imidazoles
  • Interferon-alpha
  • Nitriles
  • Pyridazines
  • Pyrimidines
  • Quinolines
  • ponatinib
  • bosutinib
  • Imatinib Mesylate
  • nilotinib
  • Dasatinib